2 Notes on the scope of the guidance

2 Notes on the scope of the guidance

NICE guidelines are developed in accordance with a scope that defines what the guideline will and will not cover.

Groups that are covered

  • Adults (18 years and older) with newly diagnosed non-small-cell lung cancer (NSCLC).

  • Adults with newly diagnosed small-cell lung cancer (SCLC).

  • Adults with relapsed NSCLC.

  • Adults with relapsed SCLC.

Groups that are not covered

  • Adults with mesothelioma.

  • Adults with lung metastases arising from primary cancers originating outside the lung.

  • Children (younger than 18) with lung cancer.

  • Adults with rare lung tumours (for example, pulmonary blastoma).

  • Adults with benign lung tumours (for example, bronchial adenoma).

How this guideline was developed

NICE commissioned the National Collaborating Centre for Cancer to develop this guideline. The Centre established a Guideline Development Group (see appendix A), which reviewed the evidence and developed the recommendations. An independent Guideline Review Panel oversaw the development of the guideline (see appendix B).

There is more information about how NICE clinical guidelines are developed on the NICE website, and in How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS.

  • National Institute for Health and Care Excellence (NICE)